Antifungal triazole alcohols: A comparative analysis of structure-activity, structure-teratogenicity and structure-therapeutic index relationships using the Multiple Computer-Automated Structure Evaluation (Multi-CASE) methodology
暂无分享,去创建一个
[1] R. Wilson,et al. Activity of ICI 195,739—a Novel, Orally Active Bistriazole—in Rodent Models of Fungal and Protozoal Infections , 1988, Annals of the New York Academy of Sciences.
[2] M J Humphrey,et al. Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans , 1985, Antimicrobial Agents and Chemotherapy.
[3] John F. Ryley,et al. Chemotherapy of Fungal Diseases , 2011, Handbook of Experimental Pharmacology.
[4] O. Flint,et al. Structure-Teratogenicity Relationships Among Antifungal Triazoles , 1990 .
[5] S. Nelson,et al. Metabolic activation and drug toxicity. , 1982, Journal of medicinal chemistry.
[6] Gilles Klopman,et al. Computer simulation of physical-chemical properties of organic molecules. 1. Molecular system identification , 1981, J. Chem. Inf. Comput. Sci..
[7] J. Graybill,et al. Systemic Azole Antifungal Drugs — Into the 1990s , 1990 .
[8] Gilles Klopman,et al. Causality in structure—activity studies , 1985 .
[9] G. Klopman. MULTICASE 1. A Hierarchical Computer Automated Structure Evaluation Program , 1992 .
[10] G. Klopman. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules , 1985 .